Related Experiment Video
Updated: Sep 18, 2025
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Diagnosis and management of cardiogenic shock
1Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine New Haven, Connecticut, USA.
Insights
Cardiogenic shock management requires early risk stratification and a continuum-based assessment. Understanding shock phenotypes, like right ventricular or mixed cardiogenic shock, is crucial for improving patient outcomes.
Area of Science:
- Cardiology
- Critical Care Medicine
- Shock Pathophysiology
Background:
- Cardiogenic shock (CS) is associated with high mortality, with limited improvements in outcomes despite decades of research.
- Acute myocardial infarction-related CS remains particularly challenging.
- Current understanding necessitates a dynamic approach to patient assessment and management.
Purpose of the Study:
- To review the current understanding of cardiogenic shock.
- To highlight the need for improved prognostic assessment and treatment strategies.
- To emphasize the importance of a continuum-based approach to CS.
Main Methods:
- Review of current literature on cardiogenic shock.
- Analysis of prognostic factors and phenotypic presentations.
- Discussion of evolving classification and management paradigms.
Main Results:
- Cardiogenic shock should be viewed as a continuum with ongoing patient assessment.
- Severity, phenotype (e.g., right ventricular, mixed CS), and concomitant conditions impact prognosis.
- Detailed classification of CS etiology aids in standardizing nomenclature and refining interventions.
Conclusions:
- Early identification and risk stratification are key to selecting appropriate treatments.
- Understanding the nuances of CS presentation is vital for effective management.
- Multidisciplinary, team-based approaches are essential for aggressive CS management.
Purpose Of Review:
Cardiogenic shock continues to portend a poor prognosis. Despite ongoing efforts over the past few decades to help improve mortality, little progress has been made in improving the short-term and long-term outcomes of patients presenting with cardiogenic shock. This is especially true of those presenting with acute myocardial infarct related cardiogenic shock.
Recent Findings:
Cardiogenic shock should be understood as a continuum. Patients can move from one stage of shock to another and hence should be assessed on an ongoing basis. Cardiogenic shock should be assessed based on the severity, the phenotypic presentation and the concomitant processes that influence prognosis. Right ventricular cardiogenic shock and mixed cardiogenic shock have been recognized as predictors of worse overall prognosis. Incorporating detailed classification of cause of cardiogenic shock into routine clinical practice and will help with standardizing nomenclature and aid in understanding of the disease process and assist in refining interventions.
Summary:
Early identification, risk stratification and understanding the nuances of presentation may help with selecting appropriate treatment strategies. Aggressive management should include multidisciplinary team-based approaches to help escalate care as needed.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:30Heart Failure V: Medical Management
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
01:30Cardiomyopathy II: Dilated Cardiomyopathy
01:29Cardiomyopathy V: Interprofessional Care
01:24Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...